Improving Surveillance for Colorectal Cancer Survivors
This study is looking for people who have recently had surgery for Stage I, II, or III colorectal cancer. It aims to find out if patient navigation services, an online education program called Current Together After Cancer (CTAC), or a combination of both can help you get the recommended follow-up care (surveillance) after your cancer treatment. Surveillance is important to find any cancer recurrence early, but many people miss these important appointments and tests. The study will measure if you complete your colonoscopy, blood tests (carcinoembryonic antigen or CEA), and imaging scans within 18 months after your surgery. There are 75 people planned to join this study, and its current status is unclear.
- Study design
- This interventional study plans to enroll 75 participants. You will be assigned to one of three groups based on your clinic location.
- What's involved
- You will receive either patient navigation services, access to the CTAC web education program, or both, within 3 months of your surgery. You will also complete surveys and have your electronic health records reviewed. You will be followed up at 3 months after joining and again 12-18 months after your surgery.
- Compensation
- Not stated in the trial record.
- Follow-up
- You will be followed up at 3 months post study-enrollment and 12-18 months after surgical resection to see if you completed your surveillance care.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education
At a glance
Conditions
Where it's being run
2 sites across 1 statesStudy leadership
- Rachel B. Issaka, MD, MAS · PRINCIPAL_INVESTIGATOR · Fred Hutch/University of Washington Cancer Consortium
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Completion of colonoscopy (stage I colorectal carcinoma patients)Up to 18 months post-surgical resection
- Completing any colonoscopy, carcinoembryonic antigen tumor marker (CEA), and cross-sectional imaging (stage II-III colorectal carcinoma patients)Up to 18 months post-surgical resection
Will compare rates of surveillance care completion 1-year (up to 18 months accounting for delays that may be due to inability accessing endoscopy) post-surgical resection across groups using chi-square tests. Will use a multivariable logistic regression model to test for factors that may be associated with increased or decreased surveillance care including patient-level demographic factors (e.g., age, sex, etc.) and available clinic-level factors (e.g., clinic size, etc.).